anmelden
SMI Expanded
2.001,93
PKT
+8,67
PKT
+0,44
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.09.25 | Givaudan Hold | Deutsche Bank AG | |
| 24.09.25 | Novartis Neutral | UBS AG | |
| 24.09.25 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 23.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.09.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 23.09.25 | Roche Buy | UBS AG | |
| 23.09.25 | Novartis Neutral | UBS AG | |
| 22.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.09.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Roche Sell | Deutsche Bank AG | |
| 18.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | Givaudan Neutral | UBS AG | |
| 17.09.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 16.09.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 16.09.25 | ams-OSRAM Equal Weight | Barclays Capital | |
| 15.09.25 | UBS Buy | Jefferies & Company Inc. | |
| 12.09.25 | Givaudan Hold | Jefferies & Company Inc. | |
| 12.09.25 | Novartis Neutral | UBS AG | |
| 12.09.25 | Swiss Re Buy | UBS AG | |
| 12.09.25 | Swiss Re Hold | Jefferies & Company Inc. | |
| 12.09.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 12.09.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 12.09.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.09.25 | Novartis Sell | Goldman Sachs Group Inc. | |
| 11.09.25 | UBS Outperform | RBC Capital Markets | |
| 11.09.25 | Richemont Outperform | Bernstein Research | |
| 10.09.25 | DocMorris Buy | Jefferies & Company Inc. | |
| 10.09.25 | Richemont Sector Perform | RBC Capital Markets | |
| 10.09.25 | Novartis Buy | Deutsche Bank AG | |
| 09.09.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 09.09.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.09.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.09.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 05.09.25 | Novartis Neutral | UBS AG | |
| 04.09.25 | Swiss Re Underweight | Barclays Capital | |
| 04.09.25 | Zurich Insurance Equal Weight | Barclays Capital |
